Period,symbol,NAV,sharesOutstanding,researchDevelopment,effectOfAccountingCharges,incomeBeforeTax,minorityInterest,netIncome,sellingGeneralAdministrative,grossProfit,ebit,operatingIncome,otherOperatingExpenses,interestExpense,extraordinaryItems,nonRecurring,otherItems,incomeTaxExpense,totalRevenue,totalOperatingExpenses,costOfRevenue,totalOtherIncomeExpenseNet,discontinuedOperations,netIncomeFromContinuingOps,netIncomeApplicableToCommonShares,intangibleAssets,capitalSurplus,totalLiab,totalStockholderEquity,totalAssets,commonStock,retainedEarnings,cash,totalCurrentLiabilities,propertyPlantEquipment,totalCurrentAssets,longTermDebt,accountsPayable,shortLongTermDebt,shortTermInvestments,otherLiab,changeToLiabilities,netBorrowings,totalCashFromFinancingActivities,changeToOperatingActivities,changeInCash,totalCashFromOperatingActivities,depreciation,changeToNetincome,investments,totalCashflowsFromInvestingActivities,WC,language,region,quoteType,triggerable,quoteSourceName,marketState,currency,exchange,shortName,market,priceHint,fullExchangeName,longName,financialCurrency,averageDailyVolume3Month,averageDailyVolume10Day,fiftyTwoWeekLowChange,fiftyTwoWeekLowChangePercent,fiftyTwoWeekRange,fiftyTwoWeekHighChange,fiftyTwoWeekHighChangePercent,fiftyTwoWeekLow,fiftyTwoWeekHigh,epsTrailingTwelveMonths,exchangeDataDelayedBy,bookValue,fiftyDayAverage,fiftyDayAverageChange,fiftyDayAverageChangePercent,twoHundredDayAverage,twoHundredDayAverageChange,twoHundredDayAverageChangePercent,marketCap,priceToBook,sourceInterval,exchangeTimezoneName,exchangeTimezoneShortName,gmtOffSetMilliseconds,esgPopulated,tradeable,regularMarketChangePercent,regularMarketDayRange,regularMarketPreviousClose,bid,ask,bidSize,askSize,messageBoardId,regularMarketPrice,regularMarketTime,regularMarketChange,regularMarketOpen,regularMarketDayHigh,regularMarketDayLow,regularMarketVolume,Beta (5Y Monthly),52-Week Change 3,S&P500 52-Week Change 3,52 Week High 3,52 Week Low 3,50-Day Moving Average 3,200-Day Moving Average 3,Avg Vol (3 month) 3,Avg Vol (10 day) 3,Shares Outstanding 5,Implied Shares Outstanding 6,Float,% Held by Insiders 1,% Held by Institutions 1,Shares Short 4,Short Ratio 4,Short % of Float 4,Short % of Shares Outstanding 4,Shares Short (prior month ) 4,Forward Annual Dividend Rate 4,Forward Annual Dividend Yield 4,Trailing Annual Dividend Rate 3,Trailing Annual Dividend Yield 3,5 Year Average Dividend Yield 4,Payout Ratio 4,Dividend Date 3,Ex-Dividend Date 4,Last Split Factor 2,Last Split Date 3,Fiscal Year Ends,Most Recent Quarter (mrq),Profit Margin,Operating Margin (ttm),Return on Assets (ttm),Return on Equity (ttm),Revenue (ttm),Revenue Per Share (ttm),Quarterly Revenue Growth (yoy),Gross Profit (ttm),EBITDA,Net Income Avi to Common (ttm),Diluted EPS (ttm),Quarterly Earnings Growth (yoy),Total Cash (mrq),Total Cash Per Share (mrq),Total Debt (mrq),Total Debt/Equity (mrq),Current Ratio (mrq),Book Value Per Share (mrq),Operating Cash Flow (ttm),Levered Free Cash Flow (ttm),index,zip,sector,fullTimeEmployees,longBusinessSummary,city,phone,state,compensationAsOfEpochDate,country,website,maxAge,address1,industry
t0,FNAM,-7004978.0,5881900,,,-513742,,-513742,417035,-96815,-513850,-513850,,,,,,0,0,513850,96815,108,,-513742,-585134,3412656.0,11999090.0,2326361.0,-3592322.0,3611253.0,5882.0,-15597294.0,97558.0,4135.0,42747.0,155850.0,2322226.0,4135.0,,,,971.0,76395.0,76395.0,3465.0,-118278.0,-194673.0,259703.0,54930.0,,,151715.0,en-US,US,EQUITY,False,Delayed Quote,POST,USD,PNK,EVOLUTIONARY GENOMICS INC,us_market,4,Other OTC,"Evolutionary Genomics, Inc.",USD,292,316,0.21000004,0.3559323,0.59 - 5.71,-4.91,-0.8598949,0.59,5.71,-0.386,0,-0.611,1.0594444,-0.25944442,-0.24488723,1.1060145,-0.30601448,-0.27668217,4705520,-1.309329,15,America/New_York,EDT,-14400000,False,False,0.0,0.8 - 0.8,0.8,0.0,0.0,0,0,finmb_266074116,0.8,1630523821,0.0,0.8,0.8,0.8,1055,0.21,,,5.71,0.59,1.0594,1.106,292,316,5.88M,,3.75M,36.26%,0.00%,,,,,,,,,,,0.00%,,,16:1000,"Oct 18, 2015","Dec 30, 2020","Mar 30, 2021",0.00%,0.00%,-50.82%,-91.55%,,0.00,,-1.78M,-2.5M,-2.27M,-0.3860,,97.56k,0.02,2.32M,180.73,37.69,-0.61,-2.46M,-1.27M,Value,80108,Healthcare,2,"Evolutionary Genomics, Inc., together with its subsidiaries, engages in the research and identification of positively selected genes in humans, animals, and commercial crops. The company develops Adapted Traits Platform, a technology platform to identify genes for enhancing crop plant traits, such as yield, sugar content, biomass, drought tolerance, and pest/disease resistance. It serves governmental organizations, non-profit foundations, and commercial entities. Evolutionary Genomics, Inc. was incorporated in 1990 and is based in Castle Rock, Colorado.",Castle Rock,720 900 8666,CO,1609372800,United States,http://www.evolgen.com,86400,1026 Anaconda Drive,Biotechnology
t-1,FNAM,-6726461.0,5881900,,,-1711154,,-1711154,470607,-1394265,-1864872,-1864872,,,,,,0,0,1864872,1394265,153718,,-1711154,-1782546,3664343.0,12015552.0,2248995.0,-3062118.0,3992699.0,5882.0,-15083552.0,215836.0,3164.0,50763.0,277593.0,2245831.0,3164.0,,,,-28862.0,1295831.0,1295831.0,-52210.0,-104800.0,-1548244.0,342577.0,-98595.0,147613.0,147613.0,274429.0,en-US,US,EQUITY,False,Delayed Quote,POST,USD,PNK,EVOLUTIONARY GENOMICS INC,us_market,4,Other OTC,"Evolutionary Genomics, Inc.",USD,292,316,0.21000004,0.3559323,0.59 - 5.71,-4.91,-0.8598949,0.59,5.71,-0.386,0,-0.611,1.0594444,-0.25944442,-0.24488723,1.1060145,-0.30601448,-0.27668217,4705520,-1.309329,15,America/New_York,EDT,-14400000,False,False,0.0,0.8 - 0.8,0.8,0.0,0.0,0,0,finmb_266074116,0.8,1630523821,0.0,0.8,0.8,0.8,1055,0.21,,,5.71,0.59,1.0594,1.106,292,316,5.88M,,3.75M,36.26%,0.00%,,,,,,,,,,,0.00%,,,16:1000,"Oct 18, 2015","Dec 30, 2020","Mar 30, 2021",0.00%,0.00%,-50.82%,-91.55%,,0.00,,-1.78M,-2.5M,-2.27M,-0.3860,,97.56k,0.02,2.32M,180.73,37.69,-0.61,-2.46M,-1.27M,Value,80108,Healthcare,2,"Evolutionary Genomics, Inc., together with its subsidiaries, engages in the research and identification of positively selected genes in humans, animals, and commercial crops. The company develops Adapted Traits Platform, a technology platform to identify genes for enhancing crop plant traits, such as yield, sugar content, biomass, drought tolerance, and pest/disease resistance. It serves governmental organizations, non-profit foundations, and commercial entities. Evolutionary Genomics, Inc. was incorporated in 1990 and is based in Castle Rock, Colorado.",Castle Rock,720 900 8666,CO,1609372800,United States,http://www.evolgen.com,86400,1026 Anaconda Drive,Biotechnology
t-2,FNAM,-5331892.0,5881900,,,-451468,,535885,336377,-138132,-474509,-474509,,,,,,-987353,0,474509,138132,23041,,535885,464493,3997391.0,12032015.0,1056294.0,-1334501.0,4456223.0,5882.0,-13372398.0,320636.0,75312.0,60292.0,398540.0,980982.0,32026.0,43286.0,68357.0,,-117558.0,800000.0,800000.0,8715.0,318185.0,-481815.0,46430.0,-955287.0,147613.0,147613.0,323228.0,en-US,US,EQUITY,False,Delayed Quote,POST,USD,PNK,EVOLUTIONARY GENOMICS INC,us_market,4,Other OTC,"Evolutionary Genomics, Inc.",USD,292,316,0.21000004,0.3559323,0.59 - 5.71,-4.91,-0.8598949,0.59,5.71,-0.386,0,-0.611,1.0594444,-0.25944442,-0.24488723,1.1060145,-0.30601448,-0.27668217,4705520,-1.309329,15,America/New_York,EDT,-14400000,False,False,0.0,0.8 - 0.8,0.8,0.0,0.0,0,0,finmb_266074116,0.8,1630523821,0.0,0.8,0.8,0.8,1055,0.21,,,5.71,0.59,1.0594,1.106,292,316,5.88M,,3.75M,36.26%,0.00%,,,,,,,,,,,0.00%,,,16:1000,"Oct 18, 2015","Dec 30, 2020","Mar 30, 2021",0.00%,0.00%,-50.82%,-91.55%,,0.00,,-1.78M,-2.5M,-2.27M,-0.3860,,97.56k,0.02,2.32M,180.73,37.69,-0.61,-2.46M,-1.27M,Value,80108,Healthcare,2,"Evolutionary Genomics, Inc., together with its subsidiaries, engages in the research and identification of positively selected genes in humans, animals, and commercial crops. The company develops Adapted Traits Platform, a technology platform to identify genes for enhancing crop plant traits, such as yield, sugar content, biomass, drought tolerance, and pest/disease resistance. It serves governmental organizations, non-profit foundations, and commercial entities. Evolutionary Genomics, Inc. was incorporated in 1990 and is based in Castle Rock, Colorado.",Castle Rock,720 900 8666,CO,1609372800,United States,http://www.evolgen.com,86400,1026 Anaconda Drive,Biotechnology
t-3,FNAM,-5888215.0,5881900,,,-294798,,-294798,143071,-167526,-310597,-310597,,,,,,0,0,310597,167526,15799,,-294798,-366190,4034291.0,12048477.0,1361205.0,-1853924.0,4170319.0,5882.0,-13908283.0,2451.0,180928.0,69822.0,66206.0,192924.0,149584.0,31344.0,45493.0,987353.0,16009.0,224268.0,224268.0,-2992.0,-8202.0,-232470.0,10181.0,39130.0,147613.0,147613.0,-114722.0,en-US,US,EQUITY,False,Delayed Quote,POST,USD,PNK,EVOLUTIONARY GENOMICS INC,us_market,4,Other OTC,"Evolutionary Genomics, Inc.",USD,292,316,0.21000004,0.3559323,0.59 - 5.71,-4.91,-0.8598949,0.59,5.71,-0.386,0,-0.611,1.0594444,-0.25944442,-0.24488723,1.1060145,-0.30601448,-0.27668217,4705520,-1.309329,15,America/New_York,EDT,-14400000,False,False,0.0,0.8 - 0.8,0.8,0.0,0.0,0,0,finmb_266074116,0.8,1630523821,0.0,0.8,0.8,0.8,1055,0.21,,,5.71,0.59,1.0594,1.106,292,316,5.88M,,3.75M,36.26%,0.00%,,,,,,,,,,,0.00%,,,16:1000,"Oct 18, 2015","Dec 30, 2020","Mar 30, 2021",0.00%,0.00%,-50.82%,-91.55%,,0.00,,-1.78M,-2.5M,-2.27M,-0.3860,,97.56k,0.02,2.32M,180.73,37.69,-0.61,-2.46M,-1.27M,Value,80108,Healthcare,2,"Evolutionary Genomics, Inc., together with its subsidiaries, engages in the research and identification of positively selected genes in humans, animals, and commercial crops. The company develops Adapted Traits Platform, a technology platform to identify genes for enhancing crop plant traits, such as yield, sugar content, biomass, drought tolerance, and pest/disease resistance. It serves governmental organizations, non-profit foundations, and commercial entities. Evolutionary Genomics, Inc. was incorporated in 1990 and is based in Castle Rock, Colorado.",Castle Rock,720 900 8666,CO,1609372800,United States,http://www.evolgen.com,86400,1026 Anaconda Drive,Biotechnology
